ANCAに関連した血管炎の診断と管理
Andreas Kronbichler1, Ingeborg M Bajema2, Annette Bruchfeld3
1Department of Internal Medicine IV, Nephrology and Hypertension, Medical University Innsbruck, Innsbruck, Austria; Department of Medicine, University of Cambridge, Cambridge, UK.
Lancet (London, England)
|February 17, 2024
まとめ
抗中性細胞性抗体 (ANCA) 関連性血管炎は,多炎と微小多炎を伴う粒状血管炎を含む,重度の自己免疫疾患である. 現代の治療は 標的となる生物学的薬と早期診断に焦点を当てて 生存率を向上させながらも 長期的な治療による毒性を強調しています
科学分野:
- リウマトロジ
- 免疫学
- 内科 医学
背景:
- 抗中性細胞性抗体 (ANCA) に関連した血管炎は,重度の自己免疫疾患である多炎と微小多炎を含む.
- これらの疾患は腎臓,肺,皮膚を含む複数の臓器に 影響する死滅性血管炎を伴う.
- 病理的な特徴には,多角性多角炎の粒状炎症が含まれ,顕微鏡性多角性多角炎には含まれません.
研究 の 目的:
- ANCAに関連した血管炎の進行管理をレビューする.
- 細胞毒薬から標的生物学的治療への移行を強調する
- グルココルチコイド依存症や長期治療による毒性の問題に対処する.
主な方法:
- ANCAに関連する血管炎の管理に関する現在の文献のレビュー.
- 21世紀の治療の動向の分析 生物学的薬と診断の進歩を含む
- 死亡率の減少と長期的発病率に焦点を当てた病気のアウトカムの検討
主要な成果:
- 管理は寛解の誘導と維持のための標的生物学的薬にシフトしました.
- ANCA検査の改善により 早期診断により 患者のアウトカムと生存率が向上しています
- 慢性腎臓疾患や 心血管疾患などの 長期的な病気の管理に 焦点を当てています
結論:
- 現代のANCA関連血管炎の治療は 生物学的治療と早期診断を優先します
- グルココルチコイドの毒性を減らすことは,新しい治療戦略を開発する上で重要な目標です.
- 患者さんの長期的な健康には 血管炎に関連する慢性的な併発症と 治療が必要です
関連する概念動画
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
334
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
334
Esophageal Varices-II: Clinical Features and Management
67
Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
67
Inflammatory Bowel Disease IV: Pharmacological Management
127
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
127
Autoimmune Disorders
436
Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune...
Concept and Mechanism of Autoimmune Diseases
The immune...
436
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
431
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
431
Acute Pancreatitis II: Clinical Manifestations and Management
124
Acute pancreatitis presents a complex medical emergency characterized by rapid onset inflammation of the pancreas, demanding timely diagnosis and management to prevent complications. The condition primarily manifests through severe upper abdominal pain that often radiates to the back. This pain intensifies following the consumption of fatty foods. Accompanying symptoms such as nausea, vomiting, abdominal distention, fever, dyspnea, cyanosis, and jaundice can vary in intensity but significantly...
124


